Skip to content

TTRX TTRX Interest Income

Interest Income at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$10M-9.1%
PTH
Pelthos Therapeutics Inc.PTHS
$1.25K-98.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$5.75M-35.7%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$2.28M-10.3%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$3.72M+7.8%

Other financials

Income statement

See full
Operating income-$1.2M-224%
Net income-$971.0K-196%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M
Total equity$6.1M+647%
Total assets$18.6M

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation

See full
Market cap$217.45M-17.7%
Enterprise value$212.24M

Returns & leverage

See full
Return on equity-118.8%
Debt / equity
Current ratio2.2×

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TTRX's interest income?
TTRX (TTRX) reported interest income of $49.68K in Q1 2026.
How has TTRX's interest income changed year-over-year?
TTRX's interest income increased by 861.8% year-over-year, from $5.17K to $49.68K.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.